Faculty

Judith A Malmgren

Affiliate Assistant Professor, Epidemiology

206-306-2613

Education

PhD Epidemiology, University of Washington, 1995
MS Epidemiology, University of Washington, 1985

Contact

206-306-2613

12025 9th Avenue NW
Seattle, WA 98177

Research Interests

Dr. Malmgren's main research focus is on breast cancer. She has been conducting registry-based studies for the last 19 years that include leukemia incidence post-breast cancer treatment, triple-negative disease, metastatic breast cancer and characteristics of mammography detected breast cancer. Her expertise is in survival analysis and risk modeling. In addition, she conducts validation analysis using SEER data. Her research has included studies of leukemia incidence post breast cancer diagnosis using SEER/Medicare data and comparison of regional metastatic breast cancer survival over time. She is currently focused on metastatic breast cancer, exceptional survivors and evaluation of lead time bias related to breast cancer detection method.

Outside of breast cancer and clinical oncology research, she is involved in health care quality improvement studies including surgical comparative effectiveness studies and randomized clinical trial set up and analysis.

Recent Publications (PubMed)

COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
(2023 Nov)
Breast Cancer Res Treat 202(1): 105-115
Malmgren JA, Guo B, Atwood MK, Hallam P, Roberts LA, Kaplan HG

Persistence of patient-detected breast cancer over time: 1990-2019.
(2023 Dec 15)
Cancer 129(24): 3862-3872
Malmgren JA, Atwood MK, Kaplan HG

Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999-2018.
(2022 Sep)
Breast Cancer Res Treat 195(2): 171-180
Kaplan HG, Malmgren JA, Guo B, Atwood MK

Continued proportional age shift of confirmed positive COVID-19 incidence over time to children and young adults: Washington State March-August 2020.
(2021)
PLoS One 16(3): e0243042
Malmgren J, Guo B, Kaplan HG

Breast cancer distant recurrence lead time interval by detection method in an institutional cohort.
(2020 Nov 20)
BMC Cancer 20(1): 1124
Kaplan HG, Malmgren JA, Atwood MK

Show complete publication list